OMERS ADMINISTRATION Corp Has $1.80 Million Stake in MetLife, Inc. $MET

Key Points

• OMERS ADMINISTRATION Corp has reduced its stake in MetLife by 14.3%, now holding 22,365 shares valued at approximately $1.80 million.
• Major institutional investors have shown significant activity, with Diamond Hill Capital Management and Nuveen LLC acquiring new positions valued at $336 million and $312 million, respectively, in the first quarter.
• MetLife's stock has a current price of $81.41, with a recent quarterly earnings report revealing an EPS of $2.02, which fell short of analyst expectations.

OMERS ADMINISTRATION Corp trimmed its holdings in shares of MetLife, Inc. (NYSE:MET - Free Report) by 14.3% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 22,365 shares of the financial services provider's stock after selling 3,718 shares during the period. OMERS ADMINISTRATION Corp's holdings in MetLife were worth $1,796,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of MET. Diamond Hill Capital Management Inc. bought a new position in MetLife in the 1st quarter valued at $336,965,000. Nuveen LLC bought a new position in MetLife in the 1st quarter valued at $312,946,000. Price T Rowe Associates Inc. MD boosted its position in MetLife by 7.4% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 26,488,146 shares of the financial services provider's stock valued at $2,126,734,000 after buying an additional 1,824,907 shares during the last quarter. GAMMA Investing LLC boosted its position in MetLife by 8,789.6% in the 1st quarter. GAMMA Investing LLC now owns 815,889 shares of the financial services provider's stock valued at $65,508,000 after buying an additional 806,711 shares during the last quarter. Finally, Universal Beteiligungs und Servicegesellschaft mbH bought a new position in MetLife in the 4th quarter valued at $62,265,000. 94.99% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of brokerages have commented on MET. Morgan Stanley decreased their price objective on MetLife from $98.00 to $94.00 and set an "overweight" rating on the stock in a research report on Monday, August 18th. Barclays increased their price objective on MetLife from $88.00 to $94.00 and gave the company an "overweight" rating in a research report on Monday, July 7th. Jefferies Financial Group raised their price target on MetLife from $100.00 to $103.00 and gave the stock a "buy" rating in a research report on Monday, August 11th. Keefe, Bruyette & Woods decreased their price objective on MetLife from $94.00 to $92.00 and set an "outperform" rating for the company in a research note on Monday, August 11th. Finally, JPMorgan Chase & Co. lifted their price objective on MetLife from $86.00 to $95.00 and gave the stock an "overweight" rating in a research note on Tuesday, July 8th. Ten analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company's stock. Based on data from MarketBeat, MetLife presently has an average rating of "Moderate Buy" and an average price target of $95.60.

MetLife Stock Performance

Shares of MET stock opened at $81.41 on Friday. The company has a debt-to-equity ratio of 0.57, a current ratio of 0.16 and a quick ratio of 0.16. The stock has a market cap of $54.14 billion, a PE ratio of 13.80, a price-to-earnings-growth ratio of 0.73 and a beta of 0.85. The stock has a 50-day moving average of $78.17 and a 200-day moving average of $78.41. MetLife, Inc. has a one year low of $65.21 and a one year high of $89.05.

MetLife (NYSE:MET - Get Free Report) last issued its quarterly earnings data on Wednesday, August 6th. The financial services provider reported $2.02 EPS for the quarter, missing the consensus estimate of $2.32 by ($0.30). The business had revenue of $17.34 billion for the quarter, compared to analyst estimates of $18.58 billion. MetLife had a return on equity of 19.88% and a net margin of 5.83%.The business's quarterly revenue was down 2.7% compared to the same quarter last year. During the same period in the previous year, the business posted $2.28 EPS. As a group, sell-side analysts expect that MetLife, Inc. will post 9.65 earnings per share for the current year.

MetLife Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 9th. Investors of record on Tuesday, August 5th will be paid a dividend of $0.5675 per share. This represents a $2.27 annualized dividend and a yield of 2.8%. The ex-dividend date of this dividend is Tuesday, August 5th. MetLife's dividend payout ratio (DPR) is presently 38.47%.

About MetLife

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.